FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies

Therapies targeting MAPK and AKT/mTOR signaling are currently being evaluated in clinical trials for several tumor types. However, recent studies suggest that these therapies may be limited due to acquired cancer cell resistance and a small therapeutic index between normal and cancer cells. The iden...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cipriano, Rocky, Miskimen, Kristy L.S., Bryson, Benjamin L., Foy, Chase R., Bartel, Courtney A., Jackson, Mark W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2013
Gaiak:
Research Papers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742833/
https://ncbi.nlm.nih.gov/pubmed/23676467
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak